Back to Portfolio
JBL

Jabil Inc

$339 35.5B market cap
Jabil Inc JBL BUFFETT / MUNGER / KLARMAN SUMMARY
1 SNAPSHOT
Price$339
Market Cap35.5B
2 BUSINESS

Jabil is a well-managed EMS company executing a strategic pivot from low-margin contract assembly toward higher-value AI infrastructure and optical connectivity via its Intel silicon photonics acquisition. The SiPh IP gives Jabil a differentiation path unavailable to pure EMS peers like Flex -- if executed, it transforms a portion of the business from commodity manufacturing into an IP-driven optical transceiver player comparable to Innolight. AI-related revenue of $13.1B (38% of total, +46% YoY) provides powerful near-term growth, while 40% share count reduction over 8 years demonstrates excellent capital allocation. However, at $339 and 27.7x forward PE, the stock prices in significant SiPh success and sustained AI capex acceleration. The core business remains thin-margin EMS with no moat on ~60% of revenue. A value investor should wait for a 20-30% pullback to $235-275 to get adequate margin of safety for what remains a partially unproven thesis.

3 MOAT None to Narrow (transitioning)

Intel SiPh IP acquisition creates rare vertical integration in optical transceivers (design + manufacturing); 1.6T pluggable transceiver launched; Ottawa CPO facility expanding; FDA/defense qualifications in healthcare/aerospace create moderate switching costs; core EMS business has no moat

4 MANAGEMENT
CEO: Michael Dastoor

Good - 80% FCF to buybacks (40% share reduction over 8 years), 20% to tuck-in M&A; Mobility divestiture at $2.2B was well-timed; SiPh acquisition is strategically sound but execution TBD

5 ECONOMICS
5.7% Op Margin
15% ROIC
59.7% ROE
45.3x P/E
1.3B FCF
95% Debt/EBITDA
6 VALUATION
FCF Yield3.7%
DCF Range275 - 350

At fair value to slightly overvalued - priced for SiPh success and continued AI acceleration that hasn't been fully demonstrated

7 MUNGER INVERSION
Kill Event Severity P() E[Loss]
SiPh integration execution - Intel couldn't make silicon photonics competitive at scale; Jabil inherits that challenge against entrenched players (Innolight, Coherent) HIGH - -
AI capex cycle risk - 38% of FY26E revenue ($13.1B) tied to AI infrastructure; hyperscaler capex slowdown would hit growth hard MED - -
8 KLARMAN LENS
Downside Case

SiPh integration execution - Intel couldn't make silicon photonics competitive at scale; Jabil inherits that challenge against entrenched players (Innolight, Coherent)

Why Market Right

Hyperscaler AI capex slowdown or pause crushes 38% of revenue base; Innolight or Broadcom dominate 1.6T/CPO market, marginalizing Jabil's SiPh position; Tariff escalation disrupts China/Mexico manufacturing operations; Recession-driven industrial/auto/healthcare capex cuts hit traditional EMS segments

Catalysts

SiPh 1.6T transceiver wins design-ins with hyperscalers, validating vertical integration thesis; AI infrastructure capex continues accelerating through CY2027, driving 20%+ revenue growth; Co-packaged optics (CPO) transition in 2027-2029 favors SiPh technology, giving Jabil structural advantage; Further margin expansion beyond 6% core operating margin from mix shift toward higher-value services; Share count reduction continues at 5-8% annually via buybacks, boosting EPS growth

9 VERDICT WAIT
B+ Quality Moderate - $1.9B cash but $3.4B total debt; net debt $1.4B manageable at ~1.1x FCF; equity deliberately thin from buybacks ($1.5B); interest coverage of 4.7x is adequate but not strong; capex declining post-Mobility improves FCF trajectory
Strong Buy$235
Buy$275
Fair Value$350

Monitor for pullback to $275 (accumulate) or $235 (strong buy); watch SiPh revenue disclosures, 1.6T design wins, CPO progress, and AI capex trends as key milestones

🧠 ULTRATHINK Deep Philosophical Analysis

Jabil Inc (JBL) - Deep Philosophical Analysis

The Silicon Photonics Bet: Can a Contract Manufacturer Become an IP Company?

The Core Question

Here is the fundamental tension in Jabil: this is a company that has spent forty years doing one thing exceptionally well -- building other people's products -- and is now trying to become something fundamentally different on a fraction of its revenue base. The Intel silicon photonics acquisition is not just a product line addition. It is an identity shift. And identity shifts in business, as in life, are among the hardest transformations to execute.

The EMS business model is one of the most Darwinian in all of capitalism. You compete on cost, on quality, on the ability to manage thousands of supply chain nodes across thirty countries without missing a beat. Your margins are thin -- 5-6% operating on a good day -- because your customers hold the power. They designed the product. They own the IP. They could, with enough effort and time, move production to your competitor down the street in Shenzhen or Guadalajara. The only thing keeping them with you is execution inertia and the pain of qualification. That is not a moat. That is a switching cost so shallow it evaporates the moment you stumble.

Jabil has thrived in this environment, which tells you the management team is operationally excellent. You don't grow from $15B to $34B in revenue, reduce your share count by 40%, and maintain above-cost-of-capital returns in EMS without being genuinely good at what you do. Michael Dastoor, the new CEO, was the CFO who engineered the Mobility divestiture and the capital return program. He understands capital allocation. That matters.

But operational excellence in EMS and building a competitive position in silicon photonics are entirely different capabilities. One requires managing logistics and labor costs across 100 facilities. The other requires deep semiconductor physics expertise, optical design innovation, and the ability to win technical specifications against Innolight -- a company that has eaten Intel's lunch in this very market for years.

Moat Meditation

The most honest assessment of Jabil's competitive position is this: 60% of the business has no moat, and the other 40% has a moat that might exist in three years if everything goes right.

Let me examine the SiPh opportunity through the Munger lens of inversion. What would have to go wrong?

First, Intel's silicon photonics division was not sold because it was thriving. It was sold because Intel, with its billions in R&D and its deep semiconductor expertise, could not compete with Innolight's cost structure and time-to-market. The Chinese optical module makers -- Innolight above all -- have a structural advantage: they are vertically integrated from design through packaging, they operate in a lower-cost environment, and they have captured the lion's share of hyperscaler 800G deployments. Jabil acquiring Intel's SiPh assets does not automatically solve the problems Intel could not solve.

Second, the 1.6T transceiver market is approaching rapidly, and Jabil has launched a product -- which is encouraging. But launching a product and winning volume production contracts with hyperscalers are very different milestones. The hyperscalers are sophisticated buyers. They will not award volume to Jabil's SiPh transceivers out of charity or because the technology is interesting. They will award it based on performance, reliability, cost, and delivery. Jabil must prove all four.

Third, the co-packaged optics (CPO) opportunity -- where silicon photonics has inherent advantages because the optical engine sits on the same package as the switch ASIC -- is real but distant. CPO at scale is likely a 2028-2030 event. That is a long time for a thesis to remain "potential."

Now, what would have to go right? The flip side is genuinely compelling:

Jabil has something that neither Flex nor Celestica nor Sanmina has: proprietary optical IP combined with world-class manufacturing scale. If the AI infrastructure buildout continues (and the physics of AI scaling suggest it will), the demand for optical interconnects at 800G, 1.6T, and eventually 3.2T will be enormous. Every GPU cluster needs thousands of transceivers. The total addressable market for datacom optics could reach $30-40B by 2028. Even a small share -- 5-10% -- would represent $1.5-4B in high-margin revenue for Jabil.

The key insight is this: Jabil does not need to beat Innolight outright. It needs to become a credible second or third source for hyperscalers who desperately want to reduce single-supplier risk. The hyperscalers are uncomfortable with their dependence on Innolight. They want alternatives. Jabil, with Intel's SiPh technology and its existing manufacturing relationships with these same hyperscalers, is perhaps the most natural alternative supplier in the world.

The Owner's Mindset

Would Buffett own this for twenty years? Almost certainly not -- and the reasons are instructive.

Buffett loves businesses where the competitive advantage is obvious, durable, and requires no genius to maintain. EMS is the opposite: the advantage, such as it is, must be re-earned every day through operational excellence. One bad quarter, one quality escape, one factory fire in the wrong location, and you lose a customer that took five years to win.

The SiPh business adds technological uncertainty that Buffett systematically avoids. He has said repeatedly that he doesn't understand technology well enough to predict who will win, and he's right to be humble about it. The optical transceiver market is evolving rapidly -- from discrete pluggables to CPO to potentially on-chip photonics -- and predicting Jabil's position five years out requires technological forecasting that even experts get wrong.

What Buffett would appreciate: the capital allocation. A 40% share count reduction in eight years, funded primarily from operating cash flow and a well-timed divestiture, is textbook value creation. The discipline of allocating 80% of FCF to buybacks when the stock was trading at 12-15x earnings (as it was for most of 2020-2023) was brilliant. At today's 28x forward PE, continued buybacks are less accretive, but the framework is sound.

Risk Inversion

What could destroy this business in a permanent sense?

The most dangerous scenario is not an AI capex slowdown (that would be painful but cyclical and recoverable). The most dangerous scenario is a technological leapfrog in optical interconnects that renders silicon photonics obsolete before Jabil can monetize the IP. If, for example, Broadcom or Nvidia develop on-chip optical I/O that eliminates the need for pluggable transceivers entirely, Jabil's SiPh investment becomes a stranded asset.

The probability of this is low in the next five years -- the physics favors pluggable and CPO architectures through at least 2030 -- but it is not zero.

More prosaically, a severe recession combined with hyperscaler capex cuts could compress Jabil's revenue by 15-20% while the fixed cost base (100+ facilities, 250,000+ employees) creates operating leverage in reverse. We saw a version of this in FY2020, when net income fell 92%. The company survived and recovered, but shareholders who bought at the peak suffered years of dead money.

Valuation Philosophy

At $339, the market is assigning Jabil a 27.7x forward PE on $12.25 of core EPS. This is generous for a company where 60% of revenue earns EMS-level margins. The SiPh optionality is real, but it is being priced as if execution is probable rather than possible.

A disciplined value investor applies a simple framework: pay for what exists today, and get the optionality for free. At $275 (22x forward PE), you are paying a fair price for a well-managed EMS company with improving margins and excellent capital allocation. The SiPh upside comes free. At $235 (19x forward PE), you are buying the EMS business at a discount and getting paid to wait for SiPh to prove itself.

At $339, you are paying for the EMS business AND a meaningful portion of the SiPh upside. That leaves no margin of safety, which is the one thing a value investor cannot do without.

The Patient Investor's Path

The right posture on Jabil is watchful patience. This is not a business to dismiss -- the transformation is genuine, the management is capable, and the AI tailwind is structural. But it is a business where time is the friend of the informed observer.

Wait for the market to give you a price that compensates for the uncertainties. That price is $275 for a starting position, $235 for aggressive accumulation. At those levels, you own a competent EMS company at a fair multiple, with a free option on what could be a genuine competitive advantage in silicon photonics.

The catalysts that could deliver those prices: an AI capex pause (inevitable, timing unknown), a tariff shock affecting Mexico/China operations, a disappointing SiPh revenue disclosure, or simply a broader market correction. Patience is not passivity -- it is the discipline to demand adequate compensation for bearing genuine uncertainty.

In the immortal words of Munger: "The big money is not in the buying and selling, but in the waiting."

Wait.

Jabil Inc (JBL) - Investment Analysis

NYSE | Electronics Manufacturing Services + Silicon Photonics

Analysis Date: 2026-04-15 | Current Price: ~$339 | Market Cap: ~$35.5B

Executive Summary

Jabil is the world's third-largest electronics manufacturing services (EMS) company, undergoing a strategic transformation from low-margin contract assembly into a higher-value player with proprietary silicon photonics IP acquired from Intel. The Mobility business divestiture (Samsung/BYD, $2.2B) in January 2024 removed $7B of low-margin revenue, improving the margin profile. AI-driven demand is now the dominant growth engine, with AI-related revenue projected at $13.1B in FY2026 (38% of total), up 46% YoY. The Intel SiPh acquisition gives Jabil rare vertical integration in optical transceivers -- a potential narrow moat in a market dominated by Innolight and Coherent. However, the stock has more than doubled in the past year, and the current valuation already prices in significant SiPh execution success.

Phase 1: Risk Assessment

1.1 Business Model Risks

Customer Concentration (HIGH)

  • Jabil's top 10 customers historically account for ~60-65% of revenue
  • Apple was formerly the largest customer (removed via Mobility divestiture)
  • Hyperscalers (likely Amazon, Microsoft, Google, Meta) now represent a growing share through AI infrastructure
  • Loss of a single hyperscaler relationship could meaningfully impact growth trajectory

Low-Margin EMS Competition (MODERATE-HIGH)

  • EMS is structurally a low-margin business: gross margins ~8-9%, operating margins ~4-5% GAAP
  • Competitors include Foxconn (Hon Hai), Flex, Celestica, Sanmina -- all competing on cost and scale
  • Switching costs are moderate: customers can dual-source or move production
  • Core operating margins have improved post-Mobility to ~5.4-5.7%, but remain thin vs. asset-light businesses

Intel SiPh Integration Risk (MODERATE)

  • Acquired Intel's silicon photonics transceiver product lines in late 2023
  • Requires building out design capability, not just manufacturing
  • Ottawa facility expansion underway for advanced photonics packaging
  • Competition from Innolight (dominant in 800G/1.6T), Coherent, Lumentum, Broadcom
  • Jabil launched 1.6T pluggable transceiver built on Intel SiPh engine -- encouraging but early
  • Risk: Intel's SiPh division was sold because Intel couldn't compete; Jabil inherited that challenge

Cyclicality (MODERATE)

  • EMS demand is tied to capex cycles of hyperscalers, industrial, auto, healthcare
  • Automotive and renewables segments currently under pressure
  • AI infrastructure spend could decelerate if hyperscaler capex normalizes
  • FY2020 net income crashed to $54M (vs. ~$700M+ in surrounding years) -- shows cyclical vulnerability

CEO Transition Risk (LOW-MODERATE)

  • Kenny Wilson removed as CEO in May 2024
  • Michael Dastoor (former CFO) elevated to CEO
  • Dastoor has deep institutional knowledge but limited external CEO track record
  • Early results encouraging: raised FY2026 guidance, strong Q2 execution

1.2 Structural/Macro Risks

  • Geopolitical: Significant manufacturing in China, Vietnam, Mexico; tariff exposure
  • AI capex cycle: If hyperscaler spending slows, JBL's highest-growth segment decelerates
  • Interest rate sensitivity: $3.4B total debt; interest expense ~$244M in FY2025
  • Goodwill/intangibles: Relatively low at $1.1B (6% of assets) -- not a major concern

Risk Assessment Score: 5.5/10 (Moderate -- manageable risks but thin margins leave little room for error)

Phase 2: Financial Analysis

2.1 Revenue Trajectory (Fiscal Years ending August 31)

FY Revenue ($B) YoY Growth Notes
2019 25.3 +14.5% Pre-pandemic
2020 27.3 +7.8% COVID resilient
2021 29.3 +7.4% Supply chain boom
2022 33.5 +14.3% Peak cycle
2023 34.7 +3.7% Mobility still included
2024 28.9 -16.8% Post-Mobility divestiture ($7B removed)
2025 29.8 +3.2% Organic growth resumes, AI ramp
2026E 34.0 +14.1% Raised guidance: AI = $13.1B

Key: Post-divestiture organic growth base of ~$26.4B. FY2026 growth is driven by AI infrastructure demand across all segments. Q2 FY2026 revenue of $8.3B was above guidance.

2.2 Profitability Metrics

FY Gross Margin Operating Margin (GAAP) Core Op Margin Net Income ($M) Core EPS
2021 8.1% 3.6% ~4.5% 696 5.61
2022 7.9% 4.2% ~5.0% 996 7.66
2023 8.3% 4.4% ~5.3% 818 8.63
2024 9.3% 7.0% 5.5% 1,388 8.47
2025 8.9% 4.0% 5.4% 657 8.90
2026E ~8.7% ~4.7% 5.7% ~1,150E 12.25

Key Observations:

  • FY2024 GAAP net income was inflated by $919M gain on Mobility divestiture
  • Core operating margins improving: 5.4% (FY25) to 5.7% (FY26E) -- post-divestiture mix improvement
  • Core EPS trajectory: $8.90 (FY25) -> $12.25 (FY26E) = +37.6% growth
  • Quarterly trend accelerating: Q1 FY26 $2.85, Q2 FY26 $2.69 (core), on track for $12.25

2.3 Cash Flow & Capital Allocation

FY Operating CF ($B) CapEx ($B) FCF ($B) Buybacks ($B) Dividends ($M)
2021 1.43 1.16 0.27 0.43 50
2022 1.65 1.39 0.27 0.70 48
2023 1.73 1.03 0.70 0.49 45
2024 1.72 0.78 0.93 2.50 42
2025 1.64 0.47 1.17 1.00 36
2026E ~1.80 ~0.50 1.30+ ~1.00 ~35

Key: FCF expanding as capex normalizes post-Mobility. $2.5B buyback in FY2024 was funded by Mobility divestiture proceeds. Capital allocation: 80% FCF to buybacks, 20% to tuck-in M&A. Dividend is token ($0.32/yr, ~0.1% yield).

2.4 Balance Sheet

Item FY2025 FY2024 FY2023
Cash $1.93B $2.20B $1.80B
Total Debt $3.37B $3.26B $3.25B
Net Debt $1.43B $1.06B $1.44B
Shareholders' Equity $1.51B $1.74B $2.87B
Net Debt/Equity 95% 61% 50%
Interest Coverage (EBIT/Int) 4.7x 11.1x 7.1x
Shares Outstanding 110.9M 124.3M 135.9M

Key: Equity has been deliberately shrinking via aggressive buybacks -- $1.51B equity supports a $35B market cap. Net debt is manageable at ~1.1x FCF. Share count has declined from 175M (FY2018) to 106M current -- a 40% reduction in 8 years.

2.5 Return Metrics

Metric FY2025 FY2024 FY2023 5-Yr Avg
ROE 43.4% 79.9%* 28.5% ~40%+
ROIC (est) ~15% ~18% ~12% ~14%
ROA 3.5% 8.0% 4.2% ~4.5%

*FY2024 ROE inflated by Mobility divestiture gain and low equity base from buybacks.

ROE is heavily influenced by leverage and buyback-driven equity reduction. More meaningful is ROIC at ~14-15% -- decent for EMS, above cost of capital, but not exceptional.

Phase 3: Moat Assessment

3.1 Traditional EMS Business -- No Moat

The core contract manufacturing business has no durable competitive advantage:

  • Customers can switch manufacturers (moderate switching costs)
  • Competition is primarily on cost, quality, and geographic footprint
  • Gross margins of 8-9% reflect commodity-like pricing power
  • Scale provides some cost advantages but not a true moat

3.2 Silicon Photonics -- Potential Narrow Moat (Emerging)

The Intel SiPh acquisition creates a differentiated position:

What Jabil Acquired:

  • Intel's pluggable optical transceiver product lines (400G, 800G)
  • Silicon photonics design IP and engineering team
  • Manufacturing know-how for SiPh-based transceivers
  • Customer relationships in the datacenter connectivity space

Why This Could Create a Moat:

  1. Vertical Integration: Jabil is now one of very few companies that can both design (SiPh IP) and manufacture optical transceivers at scale -- similar to Innolight's model
  2. IP Barrier: Silicon photonics is technically complex; Intel invested billions over a decade; replicating this IP takes years
  3. 1.6T Leadership: Jabil launched a 1.6T pluggable transceiver on Intel's SiPh engine, positioning for the next upgrade cycle
  4. AI Tailwind: Datacenter optical interconnect demand is growing 30-50% annually driven by AI cluster buildouts
  5. Co-packaged Optics (CPO): Ottawa facility building CPO capabilities -- this is the next frontier where SiPh has inherent advantages

Comparison to Fabrinet (FN):

  • FN is a pure-play optical manufacturing OSAT -- assembles transceivers for Innolight, Coherent, etc.
  • FN has no proprietary IP; it is a contract manufacturer of optical components
  • JBL with SiPh IP is more like Innolight (design + manufacturing) than FN (assembly only)
  • If SiPh execution succeeds, JBL's optical business could command FN-like margins (10%+ operating) on a portion of revenue

Risks to Moat Thesis:

  • Intel sold SiPh because they were losing to Innolight -- can Jabil succeed where Intel couldn't?
  • SiPh revenue is still a small fraction of $34B total (likely <$2B currently)
  • Established competitors (Innolight, Coherent, Broadcom) have years of lead in customer relationships
  • Co-packaged optics timeline is uncertain (2027-2029+ for meaningful volume)

3.3 Other Differentiation

  • Healthcare/Life Sciences: FDA-regulated manufacturing creates moderate switching costs
  • Defense/Aerospace: Security clearances and qualification processes create barriers
  • Automotive: IATF 16949 certification and program lifecycle lock-in
  • Geographic Diversification: 100+ facilities in 30+ countries

Moat Rating: None to Narrow (transitioning) -- SiPh IP is the moat catalyst but unproven at scale

Phase 4: Valuation & Entry Prices

4.1 Current Valuation

Metric Value Context
Price $339 Near 52-week high ($344.50)
Market Cap $35.5B
PE (TTM) 45.3x Based on GAAP $7.43 EPS
PE (Forward FY26E) 27.7x Based on core EPS $12.25
EV/EBITDA 19.0x
Price/Sales 1.09x
Price/Book 26.2x Distorted by buyback-reduced equity
FCF Yield 3.7% Based on $1.3B FCF / $35.5B mkt cap

4.2 Peer Comparison

Company FWD PE EV/EBITDA Op Margin FCF Yield Growth
JBL 27.7x 19.0x 5.7% 3.7% +14% rev, +38% EPS
FLEX 22.4x ~14x 5.5% 4.5% +8%
FN (Fabrinet) 43.6x ~33x 12.5% 2.5% +15%
CLS (Celestica) ~20x ~13x 7.0% 4.0% +20%

JBL vs. FN: JBL trades at a significant discount (27.7x vs 43.6x forward PE). If the SiPh thesis plays out and JBL's optical business scales, the multiple could re-rate toward FN's territory on that revenue stream. But JBL's blended margin will always be diluted by low-margin traditional EMS.

JBL vs. FLEX: Comparable businesses with JBL at a modest premium (27.7x vs 22.4x), justified by higher EPS growth rate (+38% vs +8%) and SiPh optionality.

4.3 Intrinsic Value Estimate

Base Case (Core EMS + Moderate SiPh Success):

  • FY2027E Core EPS: $14.00 (15% growth on AI/SiPh expansion + buybacks)
  • Fair PE: 22-25x (EMS peer average + SiPh premium)
  • Fair Value: $308 - $350
  • Current price ($339) = fair value range, no margin of safety

Bull Case (SiPh Scales, AI Demand Persists):

  • FY2027E Core EPS: $15.50 (further margin expansion to 6%+)
  • Fair PE: 28-30x (re-rated as optical IP company)
  • Fair Value: $434 - $465
  • Current price = 27% below bull case midpoint

Bear Case (AI Capex Slows, SiPh Disappoints):

  • FY2027E Core EPS: $11.00 (margin compression, revenue miss)
  • Fair PE: 16-18x (revert to pure EMS multiple)
  • Fair Value: $176 - $198
  • Current price = 71-93% above bear case

4.4 Entry Prices

Level Price Forward PE Discount to Current Rationale
Strong Buy $235 19.2x FY26E -31% EMS bear case PE with SiPh optionality free
Accumulate $275 22.4x FY26E -19% Peer-average PE, fair for quality EMS
Fair Value $330 26.9x FY26E -3% Current trajectory priced in
Current $339 27.7x FY26E -- Near all-time highs

Synthesis & Verdict

What JBL Gets Right

  1. AI infrastructure exposure: $13.1B AI revenue (38% of total) growing 46% YoY is exceptional
  2. Capital allocation: 40% share count reduction over 8 years, 80% FCF to buybacks
  3. Portfolio transformation: Mobility divestiture removed low-value revenue; margin profile improving
  4. SiPh optionality: Intel acquisition could create narrow moat in optical transceivers
  5. Execution: Beat guidance 3 consecutive quarters, raised FY2026 outlook twice

What Gives Pause

  1. Valuation is stretched: At $339, the stock has more than doubled in 12 months; most good news is priced in
  2. Core business is still EMS: ~60% of revenue has no moat, no pricing power, thin margins
  3. SiPh is unproven at scale: Intel couldn't make it work; Jabil inherits that challenge
  4. Cyclical exposure: AI capex could slow; auto/renewables already weak
  5. Leverage: Net debt of $1.4B with equity shrinking from buybacks; interest coverage only 4.7x

The Core Question

JBL is being priced as a partial AI infrastructure play (like FN), not a traditional EMS company (like FLEX). At 27.7x forward PE, the market is giving JBL credit for SiPh success that hasn't been demonstrated yet. The thesis is compelling but the stock needs to come down 20-30% to offer adequate margin of safety for a value investor.

Recommendation: WAIT

  • Quality business improving its competitive position
  • AI tailwinds are real and durable
  • SiPh IP creates genuine optionality not available to FLEX or other pure EMS peers
  • But at $339, the market already prices in significant execution success
  • Wait for a pullback to $275 (accumulate) or $235 (strong buy)

=== VERDICT: JBL | WAIT | SB:$235 | Acc:$275 | Current:$339 ===